Books+ Search Results

Sigma Proteins: Evolution of the Concept of Sigma Receptors

Title
Sigma Proteins: Evolution of the Concept of Sigma Receptors [electronic resource] / edited by Felix J. Kim, Gavril W. Pasternak.
ISBN
9783319658537
Publication
Cham : Springer International Publishing : Imprint: Springer, 2017.
Physical Description
1 online resource (VIII, 330 p. 64 illus., 32 illus. in color).
Local Notes
Access is available to the Yale community.
Access and use
Access restricted by licensing agreement.
Summary
Two sigma receptor subtypes have been proposed, sigma1 and 2. Much of our understanding of this system is based on biochemical and pharmacological characterization of the cloned sigma1 receptor subtype (Sigma1). It has become clear that sigma receptors are not canonical receptors. Sigma1 is highly conserved among mammalian species, however, it does not share significant homology with any other mammalian protein. Although a range of structurally diverse small molecules bind Sigma1 with high affinity, and it has been associated with a broad range of signaling systems, Sigma1 itself has no known signaling or enzymatic activity. The evolution of this field over nearly four decades has more recently led to a fundamental shift in the concept of “sigma receptors” to what may more accurately and generally be called sigma proteins. Largely based on traditional pharmacologic approaches, the Sigma1 protein has been associated with a broad range of signaling systems, including G-protein coupled receptors, NMDA receptors, and ion channels. Sigma proteins have been linked to a range of physiological processes, including intracellular calcium signaling, neuroprotection, learning, memory, and cognition. Emerging genetic, clinical, and mechanism focused molecular pharmacology data demonstrate the involvement of proteins in a range of pathophysiologies and disorders including neurodegenerative disease, pain, addiction, psychomotor stimulant abuse, and cancer. However, an understanding of the physiological role of sigma proteins has remained elusive. Emerging data associate Sigma1 with chaperone-like activities or molecular scaffold functions. This book aims to provide an updated perspective on this rapidly evolving field undergoing changes in fundamental concepts of key importance to the discipline of pharmacology. It focusses on the reported roles of sigma proteins in pathophysiology and on emergent therapeutic initiatives.
Variant and related titles
Springer ebooks.
Other formats
Printed edition:
Format
Books / Online
Language
English
Added to Catalog
November 02, 2017
Series
Handbook of experimental pharmacology ; 244.
Handbook of Experimental Pharmacology, 244
Contents
Preface
Historical perspective and background - including Sigma protein subtypes and ligand selectivity
Sigma imaging agents
Medicinal chemistry
3-dimensional homology models of Sigma1
Neuronal plasticity and ion channels
Opioid receptors and other GPCR
Cancer
Neurodegenerative diseases
Pain
Cognition, learning, neurological disorders
Drug abuse and addiction
Alcohol Abuse
Stroke and neuroprotection.
Also listed under
Kim, Felix J.
Pasternak, Gavril W.
SpringerLink (Online service)
Citation

Available from:

Online
Loading holdings.
Unable to load. Retry?
Loading holdings...
Unable to load. Retry?